View conference programme - The British Society for Rheumatology
View conference programme - The British Society for Rheumatology
View conference programme - The British Society for Rheumatology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
17:45 – 19:45 ARMA/BSR/SSR Event – All Welcome Pentland Auditorium<br />
A panel of service users, policy makers and health professionals will discuss the<br />
ARMA Standards of Care project and the need <strong>for</strong> strategies <strong>for</strong> musculoskeletal<br />
conditions. We are pleased to announce that the Rt. Hon. John Reid MP,<br />
Secretary of State <strong>for</strong> Health, is planning to join us <strong>for</strong> the event.<br />
20:00 – 21:30 Satellite symposia<br />
Abbott Immunology: What are your views on current anti-TNF<br />
therapy issues? Tinto/Moorfoot<br />
• Introduction from the chairman. Paul Emery<br />
• Implementing guidelines. Brian Hazleman<br />
• Funding considerations. Gabriel Panayi<br />
• Treatment goals and considerations. Duncan Porter<br />
• Screening and monitoring. David Isenberg<br />
• Cessation of therapy. Iain McInnes<br />
• Summary of key points. Paul Emery<br />
• Question and answer session.<br />
Novartis Pharmaceuticals UK Ltd: Delivering on the COX-2 promise:<br />
towards proven GI safety Sidlaw<br />
20:00 Chair’s welcome G. Nuki, Edinburgh, UK and C. Hawkey,<br />
Nottingham, UK<br />
20:05 Current issues with NSAIDs and COX-2s G. Nuki, Edinburgh, UK<br />
20:20 <strong>The</strong> emerging clinical profile of lumiracoxib<br />
A. Tyndall, Basel, Switzerland<br />
20:40 COX-2 selective inhibitors: learnings from large outcomes studies<br />
D. Walker, Newcastle, UK<br />
20:55 TARGET: the definitive outcomes study? C. Hawkey, Nottingham, UK<br />
21:15 Panel Q&A session<br />
20:25 Chair’s closing remarks G. Nuki, Edinburgh, UK and C. Hawkey,<br />
Nottingham, UK<br />
MSD Ltd: Controversies and Challenges in <strong>Rheumatology</strong> 2004<br />
To be held off-site at the Edinburgh Suite, Sheraton Grand Hotel, Edinburgh<br />
We would like to invite you on behalf of Merck Sharp & Dohme Limited to join<br />
Professor David Blake and Professor Bryan Williams along with a panel of UK<br />
rheumatologists <strong>for</strong> a clinical update followed by a battle of great (and not so<br />
great) minds in the quiz, ‘Controversies and Challenges in <strong>Rheumatology</strong>’.<br />
19:30 Buffet<br />
20:10 Welcome and introduction Chairmen<br />
20:15 Etoricoxib review – key clinical data Chairmen<br />
20:20 Questions from the audience Chairmen and Panel<br />
20:30 <strong>Rheumatology</strong> Quiz<br />
21:20 Satellite close<br />
Panel: Professor Paul Bacon, University Hospital Birmingham<br />
Professor Michael Doherty, City Hospital, Birmingham<br />
Dr Peter Hollingworth, Southmead Hospital, Bristol<br />
Professor Robert Moots, University Hospital Aintree, Liverpool<br />
Professor Gabriel Panayi, Guys Hospital, London<br />
Dr Usha Srinivasan, Princess of Wales Hospital, Bridgend<br />
Dr Doug Veale, St Vincent’s Hospital, Dublin<br />
15